Physician profile
Gene M Massey
NPI 1881727139
$1,234,324.26
in general payments reported to CMS, 2019-2025
15 companies · $335K in 2025
The $335K reported for 2025 was more than what 98% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $45K · 2020: $112K · 2021: $163K · 2022: $112K · 2023: $161K · 2024: $306K · 2025: $335K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $520K · Consulting Fee: $239K · Travel and Lodging: $40K · Food and Beverage: $2,746.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $520,234.02 |
| Consulting Fee | $238,945.00 |
| Travel and Lodging | $40,159.34 |
| Food and Beverage | $2,746.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $1,145,388.34 | 2019-2025 | Other - Miscellaneous, Ltp, Amp |
| Degen Medical, INC. | $70,230.46 | 2019-2025 | Plif, E3, Mis E3 |
| Medtronic USA, INC. | $18,081.94 | 2019-2020 | |
| Abbott Laboratories | $217.16 | 2021-2023 | Proclaim |
| Boston Scientific Corporation | $126.44 | 2019-2021 | |
| Stryker Corporation | $63.36 | 2019 | |
| Innovation Technologies INC | $45.32 | 2025 | Irrisept |
| Nuvasive, INC. | $39.57 | 2020-2021 | |
| Medtronic, INC. | $30.89 | 2025 | Intellis Adaptivestim, Inceptiv |
| Cerapedics INC. | $24.52 | 2022 | |
| Si-Bone, INC. | $19.22 | 2022 | |
| Djo, LLC | $15.07 | 2020 | |
| Depuy Synthes Sales INC. | $14.53 | 2019 | |
| Pacira Therapeutics, INC. | $14.45 | 2019 | |
| Heron Therapeutics, INC. | $12.99 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gene Massey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.